Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Leptomeningeal Metastases

Leptomeningeal Metastases

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Leptomeningeal Metastases

2 trials tracked for Leptomeningeal Metastases.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer Completed
  2. Phase 2 Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
CSF ctDNA Status Predicts Survival in Leptomeningeal Metastases: Meta-Analysis
Oncology Meta-analysis
CSF ctDNA Status Predicts Survival in Leptomeningeal Metastases: Meta-Analysis Can a Simple Test in Spinal Fluid Predict Survival for Cancer Patients?
In a meta-analysis of 14 studies (n=963), adverse baseline CSF ctDNA status was linked to worse OS (HR 2.40, 95% CI 1.73-3.33) and PFS (HR 2…
A simple spinal fluid test can predict how long someone with advanced cancer might live by spotting DNA markers linked to shorter survival t…
Mar 27, 2026